SG/CALL/MEDTRONIC/105/0.1/17.01.25 Share Price

Warrant

DE000SV1BVL1

Market Closed - Deutsche Boerse AG 20:42:56 03/07/2024 BST
0.037 EUR +5.71% Intraday chart for SG/CALL/MEDTRONIC/105/0.1/17.01.25
Current month-16.67%
1 month-16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/07/24 0.037 +5.71%
02/07/24 0.035 +2.94%
01/07/24 0.034 -19.05%
28/06/24 0.042 +13.51%
27/06/24 0.037 -5.13%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 08:42 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SV1BVL
ISINDE000SV1BVL1
Date issued 21/02/2023
Strike 105 $
Maturity 17/01/2025 (198 Days)
Parity 10 : 1
Emission price 0.63
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.77
Lowest since issue 0.034
Delta0.07x
Omega 12.51
Premium36.65x
Gearing170.35x
Moneyness 0.7350
Difference Strike 27.83 $
Difference Strike %+26.50%
Spread 0.01
Spread %21.28%
Intrinsic value 0.000000

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.17 USD
Average target price
94.02 USD
Spread / Average Target
+21.84%
Consensus